Performance of the Sysmex UF-1000i System in Screening for Significant Bacteriuria in Patients with Bladder Cancer Who Received Bacillus Calmette-Guérin Treatment
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Diagnosing urinary tract infections by urine culture is time-consuming during a Bacillus Calmette-Guérin treatment. Because the urine culture results take time to collect, patients are treated presumptively, or Bacillus Calmette-Guérin is discontinued before the results. This study evaluated the ability of the Sysmex UF-1000i system to examine the urine bacterial count and determine if it could be used to predict a positive culture. Materials and Methods: 180 patients who underwent transurethral resection for bladder tumors and received intravesical Bacillus Calmette-Guérin treatment between January 2017 and July 2018 were evaluated prospectively. For patients who received an intravesical Bacillus Calmette-Guérin treatment, urine flow cytometry, and urine cultures were assessed weekly during the treatment period. Results: During Bacillus Calmette-Guérin instillation, 44, 146, and 27 patients had bacteriuria, pyuria, and positive urine nitrite, respectively. Multivariate analysis indicated that the predictors associated with bacteriuria included the urine flow cytometry results of ＞100 bacteria/l (odds ratio, 22.73; p＜0.001) and positive urine nitrite (odds ratio, 5.67; p=0.012) at the time of sampling for positive urine culture. The area under the receiver operative characteristic curve for diagnosing bacteriuria by urine flow cytometry was 0.825. A urine flow cytometry cutoff value of ＞100 bacteria/l resulted in a sensitivity and specificity of 75% and 90.91%, respectively. Using the cutoff of ＞1,000 bacteria/l, the sensitivity and specificity were 50% and 94.85%, respectively. Conclusions: Rapid urinary tract infection diagnosis using Sysmex UF-1000i can be used to determine whether to treat an infection and to avoid unnecessary Bacillus Calmette-Guérin discontinuation and urine culture tests.
Abstract
Purpose: Diagnosing urinary tract infections by urine culture is time-consuming during a Bacillus Calmette-Guérin treatment. Because the urine culture results take time to collect, patients are treated presumptively, or Bacillus Calmette-Guérin is discontinued before the results. This study evaluated the ability of the Sysmex UF-1000i system to examine the urine bacterial count and determine if it could be used to predict a positive culture. Materials and Methods: 180 patients who underwent transurethral resection for bladder tumors and received intravesical Bacillus Calmette-Guérin treatment between January 2017 and July 2018 were evaluated prospectively. For patients who received an intravesical Bacillus Calmette-Guérin treatment, urine flow cytometry, and urine cultures were assessed weekly during the treatment period. Results: During Bacillus Calmette-Guérin instillation, 44, 146, and 27 patients had bacteriuria, pyuria, and positive urine nitrite, respectively. Multivariate analysis indicated that the predictors associated with bacteriuria included the urine flow cytometry results of ＞100 bacteria/l (odds ratio, 22.73; p＜0.001) and positive urine nitrite (odds ratio, 5.67; p=0.012) at the time of sampling for positive urine culture. The area under the receiver operative characteristic curve for diagnosing bacteriuria by urine flow cytometry was 0.825. A urine flow cytometry cutoff value of ＞100 bacteria/l resulted in a sensitivity and specificity of 75% and 90.91%, respectively. Using the cutoff of ＞1,000 bacteria/l, the sensitivity and specificity were 50% and 94.85%, respectively. Conclusions: Rapid urinary tract infection diagnosis using Sysmex UF-1000i can be used to determine whether to treat an infection and to avoid unnecessary Bacillus Calmette-Guérin discontinuation and urine culture tests.
참고문헌 (30)
- Haresh KP, "A prospective study evaluating surgery and chemo radiation in muscle invasive bladder cancer", J Cancer Res Ther, 3, pp.81~85 (2007)
- Divrik RT, "Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival : a prospective randomised clinical trial", Eur Urol, 58, pp.185~190 (2010)
- Hall MC, "Guideline for the management of nonmuscle invasive bladder cancer(stages Ta, T1, and Tis) : 2007 update", J Urol, 178, pp.2314~2330 (2007)
- Thrasher JB, "Complications of intravesical chemotherapy", Urol Clin North Am, 19, pp.529~539 (1992)
- Abrams P, "Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee : evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence", Neurourol Urodyn, 29, pp.213~240 (2010)
- Azuma T, "Pyuria predicts poor prognosis in patients with non-muscle-invasive bladder cancer", Clin Genitourin Cancer, 11, pp.331~336 (2013)
- Millan-Lou MI, "Validation and search of the ideal cut-off of the Sysmex UF-1000i® flow cytometer for the diagnosis of urinary tract infection in a tertiary hospital in Spain", Front Med(Lausanne), 5, pp.92~ (2018)
- Broeren MA, "Screening for urinary tract infection with the Sysmex UF-1000i urine flow cytometer", J Clin Microbiol, 49, pp.1025~1029 (2011)
- De Rosa R, "Evaluation of the Sysmex UF1000i flow cytometer for ruling out bacterial urinary tract infection", Clin Chim Acta, 411, pp.1137~1142 (2010)
- Kadkhoda K, "UF-1000i flow cytometry is an effective screening method for urine specimens", Diagn Microbiol Infect Dis, 69, pp.130~136 (2011)
- Manoni F, "Urine particle evaluation : a comparison between the UF-1000i and quantitative microscopy", Clin Chem Lab Med, 48, pp.1107~1111 (2010)
- Shang YJ, "Systematic review and meta-analysis of flow cytometry in urinary tract infection screening", Clin Chim Acta, 424, pp.90~95 (2013)
- van der Zwet WC, "Evaluation of the Sysmex UF-1000i® urine flow cytometer in the diagnostic work-up of suspected urinary tract infection in a Dutch general hospital", Clin Chem Lab Med, 48, pp.1765~1771 (2010)
- Wang J, "Evaluation of the Sysmex UF-1000i for the diagnosis of urinary tract infection", Am J Clin Pathol, 133, pp.577~582 (2010)
- Yang CC, "Rapid differentiation of cocci", mixed bacteria from rods in voided urine culture of women with uncomplicated urinary tract infections, 2017, pp.31, e22071~
- Satake N, "Prognostic value of preoperative pyuria in patients with non-muscle-invasive bladder cancer", Int J Urol, 22, pp.645~649 (2015)
- Janknegt RA, "Prophylaxis in urological surgery", Infection, 20(Suppl 3), pp.S213~S216 (1992)
- Westenfelder M, "Development of nosocomial and iatrogenic urinary tract infections (UTI) following urological interventions. A prospective clinical study", Scand J Urol Nephrol Suppl, 104, pp.59~63 (1987)
- Herr HW, "Intravesical bacillus Calmette-Guerin outcomes in patients with bladder cancer and asymptomatic bacteriuria", J Urol, 187, pp.435~437 (2012)
- Zhao LC, "Screening urine analysis before bacille Calmette-Guerin instillation does not reduce the rate of infectious complications", BJU Int, 109, pp.1819~1821 (2012)
- Babjuk M, "EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016", Eur Urol, 71, pp.447~461 (2017)
- Brausi M, "Side effects of Bacillus Calmette-Guerin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full dose and 1 year with 3 years of maintenance BCG", Eur Urol, 65, pp.69~76 (2014)
- Decaestecker K, "Managing the adverse events of intravesical bacillus Calmette-Guerin therapy", Res Rep Urol, 7, pp.157~163 (2015)
- Perez-Jacoiste Asin MA, "Bacillus Calmette-Guerin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer:incidence, risk factors, and outcome in a single-institution series and review of the literature", Medicine(Baltimore), 93, pp.236~254 (2014)
- Billips BK, "Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli", Infect Immun, 75, pp.5353~5360 (2007)
- Poletajew S, "Safety and efficacy of intravesical Bacillus Calmette-Guerin immunotherapy in patients with non-muscle-invasive bladder cancer presenting with asymptomatic bacteriuria: a systematic review", Urol Int, 99, pp.1~5 (2017)
- Deville WL, "The urine dipstick test useful to rule out infections. A meta-analysis of the accuracy", BMC Urol, 4, pp.4~ (2004)
- Jolkkonen S, "Screening of urine samples by flow cytometry reduces the need for culture", J Clin Microbiol, 48, pp.3117~3121 (2010)
- Manoni F, "Cutoff values for bacteria and leukocytes for urine flow cytometer Sysmex UF-1000i in urinary tract infections", Diagn Microbiol Infect Dis, 65, pp.103~107 (2009)
- Pieretti B, "Diagnosis of bacteriuria and leukocyturia by automated flow cytometry compared with urine culture", J Clin Microbiol, 48, pp.3990~3996 (2010)